Non-random integration of the HPV genome in cervical cancer

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Schmitz, Martina ^a   Driesch, Corina ^a   Jansen, Lars ^a   Runnebaum, Ingo B ^a   Dürst, Matthias ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; CARCINOGENESIS; CHROMOSOME 3Q; CHROMOSOME BAND; CONTROLLED STUDY; CYTOGENETICS; DNA RECOMBINATION; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROMOTER REGION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; UTERINE CERVIX CANCER; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; VIRUS GENE E5; VIRUS GENE L2; VIRUS GENOME; VIRUS TRANSCRIPTION;

ALPHAPAPILLOMAVIRUS; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENOME, VIRAL; HUMANS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84862992567     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039632     Document Type: Article

References (55)

1. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
2. Durst M, Kleinheinz A, Hotz M, Gissmann L, (1985) The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol 66 (Pt 7): 1515-1522.
3. Wentzensen N, Vinokurova S, von Knebel Doeberitz M, (2004) Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 64: 3878-3884.
4. Pett M, Coleman N, (2007) Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 212: 356-367.
5. Kalantari M, Blennow E, Hagmar B, Johansson B, (2001) Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol 10: 46-54.
6. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59: 6132-6136.
7. Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, et al. (2008) Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Research 68: 307-313.
8. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, et al. (2005) The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. Journal of the National Cancer Institute 97: 1072-1079.
9. Romanczuk H, Howley PM, (1992) Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proceedings of the National Academy of Sciences of the United States of America 89: 3159-3163.
10. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, et al. (1987) Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. Journal of virology 61: 962-971.
11. Hafner N, Driesch C, Gajda M, Jansen L, Kirchmayr R, et al. (2008) Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 27: 1610-1617.
12. Peter M, Stransky N, Couturier J, Hupe P, Barillot E, et al. (2010) Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. J Pathol 221: 320-330.
13. Reuter S, Bartelmann M, Vogt M, Geisen C, Napierski I, et al. (1998) APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. Embo J 17: 215-222.
14. Schmitz M, Driesch C, Beer-Grondke K, Jansen L, Runnebaum IB, et al. (2012) Loss of gene function as a consequence of human papillomavirus DNA integration. International journal of cancer Journal international du cancer.
15. Ferber MJ, Thorland EC, Brink AA, Rapp AK, Phillips LA, et al. (2003) Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 22: 7233-7242.
16. Popescu NC, DiPaolo JA, (1990) Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines. Cancer Research 50: 1316-1323.
17. Peter M, Rosty C, Couturier J, Radvanyi F, Teshima H, et al. (2006) MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene 25: 5985-5993.
18. Koopman LA, Szuhai K, van Eendenburg JD, Bezrookove V, Kenter GG, et al. (1999) Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines. Cancer Res 59: 5615-5624.
19. Thorland EC, Myers SL, Gostout BS, Smith DI, (2003) Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 22: 1225-1237.
20. Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, et al. (2003) A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 22: 3977-3984.
21. Kraus I, Driesch C, Vinokurova S, Hovig E, Schneider A, et al. (2008) The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res 68: 2514-2522.
22. Iorio MV, Croce CM, (2009) MicroRNAs in cancer: small molecules with a huge impact. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 27: 5848-5856.
23. Calin GA, Croce CM, (2006) MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25: 6202-6210.
24. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, et al. (2008) Altered MicroRNA expression in cervical carcinomas. Clinical cancer research: an official journal of the American Association for Cancer Research 14: 2535-2542.
25. Lui WO, Pourmand N, Patterson BK, Fire A, (2007) Patterns of known and novel small RNAs in human cervical cancer. Cancer Research 67: 6031-6043.
26. Cheng AM, Byrom MW, Shelton J, Ford LP, (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic acids research 33: 1290-1297.
27. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, et al. (2008) Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27: 2575-2582.
28. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America 103: 2257-2261.
29. Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, et al. (2009) Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 15: 637-647.
30. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Molecular cell 26: 745-752.
31. Cho WC, (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. The international journal of biochemistry & cell biology 42: 1273-1281.
32. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, et al. (2010) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. The lancet oncology 11: 136-146.
33. You J, (2010) Papillomavirus interaction with cellular chromatin. Biochimica et biophysica acta 1799: 192-199.
34. Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K, (2003) The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proceedings of the National Academy of Sciences of the United States of America 100: 8758-8763.
35. Choi YW, Bae SM, Kim YW, Lee HN, Park TC, et al. (2007) Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society 17: 687-696.
36. Prazeres H, Torres J, Rodrigues F, Pinto M, Pastoriza MC, et al. (2011) Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells. Oncogene 30: 1302-1317.
37. Lu YJ, Wu CS, Li HP, Liu HP, Lu CY, et al. (2010) Aberrant methylation impairs low density lipoprotein receptor-related protein 1B tumor suppressor function in gastric cancer. Genes, Chromosomes & Cancer 49: 412-424.
38. Liu CX, Musco S, Lisitsina NM, Yaklichkin SY, Lisitsyn NA, (2000) Genomic organization of a new candidate tumor suppressor gene, LRP1B. Genomics 69: 271-274.
39. Nagayama K, Kohno T, Sato M, Arai Y, Minna JD, et al. (2007) Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution. Genes, Chromosomes & Cancer 46: 1000-1010.
40. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069-1075.
41. Kohno T, Otsuka A, Girard L, Sato M, Iwakawa R, et al. (2010) A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. Genes, Chromosomes & Cancer 49: 342-352.
42. Sonoda I, Imoto I, Inoue J, Shibata T, Shimada Y, et al. (2004) Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Research 64: 3741-3747.
43. Nakagawa T, Pimkhaokham A, Suzuki E, Omura K, Inazawa J, et al. (2006) Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma. Cancer science 97: 1070-1074.
44. Li Y, Knisely JM, Lu W, McCormick LM, Wang J, et al. (2002) Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration. The Journal of biological chemistry 277: 42366-42371.
45. Shah R, Smith P, Purdie C, Quinlan P, Baker L, et al. (2009) The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer. British journal of cancer 100: 1687-1696.
46. Vasilescu F, Ceausu M, Tanase C, Stanculescu R, Vladescu T, et al. (2009) P53, p63 and Ki-67 assessment in HPV-induced cervical neoplasia. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 50: 357-361.
47. Nishi H, Isaka K, Sagawa Y, Usuda S, Fujito A, et al. (1999) Mutation and transcription analyses of the p63 gene in cervical carcinoma. International journal of oncology 15: 1149-1153.
48. Santamarina-Fojo S, Haudenschild C, Amar M, (1998) The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Current opinion in lipidology 9: 211-219.
49. Sauermann M, Sahin O, Sultmann H, Hahne F, Blaszkiewicz S, et al. (2008) Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells. Oncogene 27: 1320-1326.
50. Chan JA, Krichevsky AM, Kosik KS, (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Research 65: 6029-6033.
51. Liu M, Wu H, Liu T, Li Y, Wang F, et al. (2009) Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell research 19: 828-837.
52. Schmitz M, Scheungraber C, Herrmann J, Teller K, Gajda M, et al. (2009) Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 44: 302-307.
53. Dall KL, Scarpini CG, Roberts I, Winder DM, Stanley MA, et al. (2008) Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions. Cancer Res 68: 8249-8259.
54. Matovina M, Sabol I, Grubisic G, Gasperov NM, Grce M, (2009) Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol 113: 120-127.
55. Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, et al. (2002) Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene 21: 419-426.